Trials / Conditions / Charcot-Marie-Tooth Disease Type 1A

Charcot-Marie-Tooth Disease Type 1A

7 registered clinical trials studyying Charcot-Marie-Tooth Disease Type 1A — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A NCT07140614	Novartis Pharmaceuticals	Phase 1
Recruiting	Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease NCT07049588	Assistance Publique Hopitaux De Marseille	N/A
Completed	Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A NCT06328712	ENCell	Phase 1
Completed	SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study NCT02967679	MedDay Pharmaceuticals SA	Phase 2
Active Not Recruiting	Tools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and Biomarkers NCT02596191	Assistance Publique Hopitaux De Marseille	N/A
Completed	Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) NCT02579759	Pharnext S.C.A.	Phase 3
Unknown	Treadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neur NCT01289704	University of Genova	Phase 2 / Phase 3